MedPath

Safety Study of SPARC1104

Phase 3
Completed
Conditions
Spasticity
Interventions
Drug: SPARC1104 modified dose regimen I
Drug: SPARC1104 modified dose regimen II
Drug: SPARC1104 modified dose regimen III
Registration Number
NCT01797185
Lead Sponsor
Sun Pharma Advanced Research Company Limited
Brief Summary

Open-label, safety study of SPARC1104 in subjects with spasticity due to multiple sclerosis

Detailed Description

Safety study of SPARC1104

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
375
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SPARC1104 group 1SPARC1104 modified dose regimen I-
SPARC1104 group 2SPARC1104 modified dose regimen II-
SPARC1104 group 3SPARC1104 modified dose regimen III-
Primary Outcome Measures
NameTimeMethod
Number of Subjects With Adverse Events52 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (50)

SPARC Site 11

🇺🇸

Port Charlotte, Florida, United States

SPARC Site 24

🇺🇸

Overland Park, Kansas, United States

SPARC Site 34

🇺🇸

Phoenix, Arizona, United States

SPARC Site 58

🇺🇸

Milwaukee, Wisconsin, United States

SPARC Site 59

🇺🇸

Miami, Florida, United States

SPARC Site 54

🇺🇸

Detroit, Michigan, United States

SPARC Site 37

🇺🇸

Houston, Texas, United States

SPARC Site 30

🇺🇸

Costa Mesa, California, United States

SPARC site 47

🇺🇸

Hartford, Connecticut, United States

SPARC Site 16

🇺🇸

Albuquerque, New Mexico, United States

SPARC Site 27

🇺🇸

Centerville, Ohio, United States

SPARC Site 20

🇺🇸

Tacoma, Washington, United States

SPARC Site 62

🇺🇸

Huntington, West Virginia, United States

SPARC Site 52

🇺🇸

White Plains, New York, United States

SPARC site 39

🇺🇸

Charlotte, North Carolina, United States

SPARC Site 1

🇺🇸

Tucson, Arizona, United States

SPARC site 4

🇺🇸

Gilbert, Arizona, United States

SPARC Site 14

🇺🇸

Newport Beach, California, United States

SPARC Site 7

🇺🇸

Derby, Connecticut, United States

SPARC Site 32

🇺🇸

Basalt, Colorado, United States

SPARC Site 50

🇺🇸

Washington, District of Columbia, United States

SPARC Site 8

🇺🇸

New London, Connecticut, United States

SPARC Site 35

🇺🇸

Maitland, Florida, United States

SPARC Site 6

🇺🇸

Ormond Beach, Florida, United States

SPARC Site 25

🇺🇸

Sunrise, Florida, United States

SPARC Site 13

🇺🇸

Sarasota, Florida, United States

SPARC site 45

🇺🇸

Lenexa, Kansas, United States

SPARC Site 21

🇺🇸

Baton Rouge, Louisiana, United States

SPARC Site 22

🇺🇸

Fulton, Maryland, United States

SPARC Site 49

🇺🇸

Baltimore, Maryland, United States

SPARC site 36

🇺🇸

Alexandria, Louisiana, United States

SPARC Site 17

🇺🇸

Springfield, Massachusetts, United States

SPARC Site 26

🇺🇸

Clinton Township, Michigan, United States

SPARC Site 29

🇺🇸

Foxboro, Massachusetts, United States

SPARC Site 43

🇺🇸

Rochester, New York, United States

SPARC Site 28

🇺🇸

Flemington, New Jersey, United States

SPARC Site 19

🇺🇸

Golden Valley, Minnesota, United States

SPARC Site 18

🇺🇸

Greensboro, North Carolina, United States

SPARC Site 57

🇺🇸

Abington, Pennsylvania, United States

SPARC site 38

🇺🇸

Springfield, Oregon, United States

SPARC site 10

🇺🇸

Eugene, Oregon, United States

SPARC Site 23

🇺🇸

Indian Land, South Carolina, United States

SPARC Site 60

🇺🇸

Dallas, Texas, United States

SPARC Site 56

🇺🇸

Waukesha, Wisconsin, United States

SPARC Site 44

🇺🇸

Louisville, Kentucky, United States

SPARC Site 61

🇺🇸

New Orleans, Louisiana, United States

SPARC Site 5

🇺🇸

Austin, Texas, United States

SPARC Site 33

🇺🇸

Tampa, Florida, United States

SPARC Site 55

🇺🇸

Tampa, Florida, United States

SPARC Site 2

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath